Experimental Covid-19 vaccine produces antibodies in 100pc of US trial participants
An experimental COVID-19 vaccine that is being developed by US biotech firm Moderna induced antibody responses against the coronavirus in all 45 participants - Reuters/ An experimental Covid-19 vaccine that is being developed by US biotech firm Moderna induced antibody responses against the coronavirus in all 45 participants of a human trial, a paper published Tuesday showed. Moderna had previously published "interim results" from its Phase 1 in the form of a press release on its website in May, which revealed the vaccine had generated ...
Click
To Read Full Article